Immunovant (IMVT) Stock News
$IMVT · NASDAQ · 3 stories in 30 daysBORSA has published 3 stories on Immunovant (IMVT) in the past 30 days. BORSA’s news read on IMVT is leaning bearish at 44/100, +1 over 24 hours, based on 3 company events over the past 30 days. IMVT last closed at $30.47 on Oct 9, down 9.37% over five sessions and down 20.03% over the past month. Immunovant’s next earnings report is scheduled for Monday, Nov 9.
The wire on $IMVT
newest first · updated · direct subject stories onlyImmunovant faces securities investigation after lupus trial miss, stock fell 6%
Immunovant (IMVT) stock fell ~6% on Sept 23 after IMVT-1402 cutaneous lupus study missed primary endpoint; program discontinued. Law firm Levi & Korsinsky announces investigation into potential securities law violations. Stock hit more-than-three-month low.
bearish 35 · impact 40